• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 9, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

ECNP Notes Growing Citations Highlight Interest in Mental Health Biology

Bioengineer by Bioengineer
July 9, 2026
in Biology
Reading Time: 2 mins read
0
ECNP Notes Growing Citations Highlight Interest in Mental Health Biology
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Two prominent journals at the intersection of biology and mental health have recently reported notable increases in their citation metrics, underscoring growing scientific engagement in these research domains. European Neuropsychopharmacology, a subscription-based journal with a longstanding presence, announced its Impact Factor rising significantly from 6.7 in 2024 to 8.1 in 2025. Meanwhile, Neuroscience Applied, an open-access journal launched in 2022 by the European College of Neuropsychopharmacology (ECNP), reported its inaugural Impact Factor at an impressive 3.0.

Impact Factors, a widely recognized metric in academic publishing, indicate the average frequency with which recently published articles are cited in other scholarly work. An increase typically signals enhanced relevance and influence within the scientific community. The ECNP, which owns both journals and partners with Elsevier for publication, positions itself at the forefront of applied neuroscience research, facilitating dissemination through these high-impact outlets.

Professor Eduard Vieta, Editor-in-Chief of European Neuropsychopharmacology and a leading figure at the University of Barcelona, attributes the journal’s rising prominence to strategic editorial policies designed to elevate article quality and impact. The editorial board implemented rigorous initial screening to swiftly exclude submissions unlikely to be cited, focusing on manuscripts with robust methodologies and adequate sample sizes. This deliberate tightening of selection criteria aligns with a broader surge in research exploring the biological underpinnings of psychiatric conditions, particularly within the framework of “precision psychiatry,” a field aiming to tailor interventions based on individual biological profiles.

In parallel, Neuroscience Applied’s Editor-in-Chief, Professor Andreas Meyer-Lindenberg of the University of Heidelberg and the Central Institute of Mental Health Mannheim, expressed optimism about the journal’s rapid progression. Achieving a respectable Impact Factor in its early stage reflects both effective publication strategies and a timely entry into a scientific landscape increasingly attuned to applied neuroscience. Its fully open-access model removes traditional paywall barriers, potentially accelerating visibility and citation rates as it navigates a competitive journal environment.

The significant Impact Factor boost enables European Neuropsychopharmacology to ascend into the top quartile among Psychiatry journals, ranking 13th out of 293 in its category. This success reflects a reinforcing cycle where publishing high-caliber research attracts citations, further elevating the journal’s stature and appeal to authors and readers alike.

Such developments highlight broader trends in the neuropsychiatric research community, where advances in neurobiology and methodological rigor drive burgeoning scientific interest. The emphasis on precision psychiatry—leveraging biological markers to stratify mental health disorders—mirrors a paradigm shift toward more targeted and effective therapeutic approaches, a focus mirrored by the editorial directions of these journals.

As these journals continue to attract influential research contributions, they serve as critical platforms fostering interdisciplinary dialogue between biology, neuroscience, and clinical psychiatry. Their rising Impact Factors not only represent academic metrics but also suggest a deepening engagement with pressing mental health challenges through innovative scientific inquiry.

With the ECNP hosting its annual congress in Munich in October 2026, these journals’ growing influence is expected to invigorate discussions and collaborations, further catalyzing advancements in applied neuroscience and neuropsychopharmacology.

Subject of Research: Not applicable
Keywords: Scientific publishing, Academic publishing, Science communication, Psychiatry, Neurology, Psychiatric disorders, Neurological disorders

Tags: applied neuroscience research disseminationcitation metrics in neuroscienceECNP scientific influenceeditorial strategies for high-impact publicationsEuropean College of Neuropsychopharmacology initiativesEuropean Neuropsychopharmacology publication trendsgrowth in mental health biology researchjournal impact factor analysismental health researchneuropsychopharmacology journal impact factorsNeuroscience Applied open-access journalscientific engagement in mental health biology

Share12Tweet7Share2ShareShareShare1

Related Posts

California Gray Wolves Mainly Consume Cattle, Raising Human-Wildlife Conflicts

California Gray Wolves Mainly Consume Cattle, Raising Human-Wildlife Conflicts

July 9, 2026
Improved survival rates found for babies with severe fetal disorders

Improved survival rates found for babies with severe fetal disorders

July 9, 2026

Standard fetal growth charts frequently miss identifying at-risk babies

July 9, 2026

ISSCR 2026 Launches in Montréal with Global Stem Cell Science Summit

July 8, 2026

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Insilico Medicine Reports First Half 2026 Positive Profit Alert

California Gray Wolves Mainly Consume Cattle, Raising Human-Wildlife Conflicts

BET inhibition reveals glycolytic vulnerability via HIF1α in triple-negative breast cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.